Publicaciones en colaboración con investigadores/as de Istituto Superiore di Sanità (18)

2024

  1. Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival

    European Journal of Endocrinology, Vol. 190, Núm. 1, pp. 62-74

2022

  1. Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses

    Circulation, Vol. 146, Núm. 20, pp. 1507-1517

2021

  1. Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials (European Journal of Clinical Pharmacology, (2021), 77, 1, (1-12), 10.1007/s00228-020-02951-8)

    European Journal of Clinical Pharmacology

  2. Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials

    European Journal of Clinical Pharmacology, Vol. 77, Núm. 1

2020

  1. External quality assessment schemes for inorganic elements in the clinical laboratory: Lessons from the OELM scheme

    Journal of Trace Elements in Medicine and Biology, Vol. 59

  2. Two multi-fragment recombination events resulted in the β-lactam-resistant serotype 11A-ST6521 related to Spain9V-ST156 pneumococcal clone spreading in south-western Europe, 2008 to 2016

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 25, Núm. 16

2019

  1. Equalization of four cardiovascular risk algorithms after systematic recalibration: Individual-participant meta-analysis of 86 prospective studies

    European Heart Journal, Vol. 40, Núm. 7, pp. 621-631

2018

  1. Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 4, pp. 816-826

  2. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 1, pp. 64-76

  3. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies

    The Lancet, Vol. 391, Núm. 10129, pp. 1513-1523

2017

  1. Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis

    American Journal of Epidemiology, Vol. 186, Núm. 8, pp. 899-907

2015

  1. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

2014

  1. Glycated hemoglobin measurement and prediction of cardiovascular disease

    JAMA - Journal of the American Medical Association, Vol. 311, Núm. 12, pp. 1225-1233

2012

  1. The CREATE project: Development of certified reference materials for allergenic products and validation of methods for their quantification

    Advanced Topics in Science and Technology in China (Springer), pp. 149-179

2010

  1. Assessing the burden of paediatric influenza in Europe: The European paediatric influenza analysis (EPIA) project

    European Journal of Pediatrics, Vol. 169, Núm. 8, pp. 997-1008

2009

  1. Major lipids, apolipoproteins, and risk of vascular disease

    JAMA, Vol. 302, Núm. 18, pp. 1993-2000

2003

  1. A European survey of diagnostic methods and testing protocols for Clostridium difficile

    Clinical Microbiology and Infection, Vol. 9, Núm. 10, pp. 989-996

2001

  1. Duration of ruptured membranes and vertical transmission of HIV-1: A meta-analysis from 15 prospective cohort studies

    AIDS, Vol. 15, Núm. 3, pp. 357-368